Cancer Treatment

Shares of Juno Therapeutics Inc (NASDAQ: JUNO) have gained more nearly 30 percent over the past three months, but are lower by more than 10 percent over the past five days. Despite recent weakness in Juno's stock, the Vetr crowd upgraded the issue to four stars out of a possible five...

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged more than 18 percent on Thursday. Roddy Boyd of SIRF wrote a scathing research report on Thursday titled "Murder Incorporated: Insys Therapeutics" in which he argued the company is ‘in a great deal of trouble.'...